James N Ingle

24PUBLICATIONS
171CO-AUTHORS
Epidemiological methodsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersEnvironmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|May 12, 2026
Establishment of harmonized international reference ranges for plasma estradiol concentrations in postmenopausal women.

|Oct 24, 2025
CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial.

Andrea E Wahner Hendrickson, Karen S Flatten, Taylor M Weiskittel

|Aug 28, 2025
Reply to: "Rethinking Treatment Priorities in Estrogen Receptor-Low Breast Cancer" and "CDK4/6 Inhibitors in Estrogen Receptor-Low Breast Cancer".

Matthew P Goetz, Grace M Choong, Tanya L Hoskin

|Jun 23, 2025
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.

Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta

|Apr 11, 2025
Endocrine Therapy Omission in Estrogen Receptor-Low (1%-10%) Early-Stage Breast Cancer.

Grace M Choong, Tanya L Hoskin, Judy C Boughey

|Mar 20, 2025
Evaluation of the androgen receptor in patients with ERα-positive early breast cancer treated with adjuvant tamoxifen ± fluoxymesterone.

James N Ingle, Vera J Suman, Malvika H Solanki

Pageof 4

Frequent Collaborators

12 joint publications

Matthew P Goetz

7 joint publications

Judy C Boughey

4 joint publications

Jason Sinnwell

3 joint publications

Bingshu E Chen